Day One

Explore the Agenda

8:00 am Registration & Light Breakfast

8:50 am Chair’s Opening Remarks

Aligning Global Filing Decisions to Optimize Cost, Risk & Market Impact

9:00 am Panel Discussion: Evaluating Global Filing Priorities to Balance Reach & Cost Efficiency

Synopsis

  • Compare global IP filing strategies under budget and access constraints
  • Explore prioritization across U.S., EU, Asia, and emerging markets
  • Understand enforcement considerations in key jurisdictions

9:45 am Audience Discussion: Drafting Across US & EU Systems to Strengthen Global Enforceability

Synopsis

  • Navigate differences in patentability standards and claim formats
  • Learn drafting tactics to reduce rejections across both systems
  • Prepare for downstream opposition and litigation risks globally

10:15 am Speed Networking

Synopsis

Elevate your networking experience by joining the speed networking session tailored for in-house IP 

experts, like yourselves, to connect with industry peers and facilitate rapid yet meaningful exchanges 

of insights and expertise.

11:00 am Morning Break & Networking

Linking Budget-Conscious Filing to Securing Funding & Investor Confidence

11:20 am Presentation: Building Lean Portfolios to Secure Investment Without Overspending

Synopsis

  • Craft defensible IP on limited early-stage budgets
  • Prioritize filings that demonstrate commercial potential
  • Avoid over-patenting while showing strategic foresight

11:50 am Presentation: Reverse-Engineering Term Sheets to Align IP Strategy with Business Goals

Synopsis

  • Deconstruct how funding deals reveal implicit IP priorities
  • Learn how to tailor patent timing to capital events
  • Understand term sheet language that signals future IP leverage

12:20 pm Fireside Chat: How Founder-Led IP Strategy Drives Differentiation, Investor Confidence, and Commercial Impact

  • Raphaël Ognar President & Chief Executive Officer & Co-Founder & Chairman of the Board, NKILT Therapeutics

Synopsis

  • Learn how a founder-led approach to IP creation drives strategy and differentiation from the outset
  • Understand the practical interplay between IP maturity, investor conversations, and biotech valuation
  • Gain insight into common investor misconceptions around IP and how to overcome them in funding discussions

12:50 pm Lunch & Networking

Strategically Timing Patent Filings to Extend Exclusivity & Delay the Patent Cliff

1:50 pm Panel Discussion: Timing Patent Filings to Maximize Lifecycle Value & Market Impact

  • Christina Jordan Senior Director, Intellectual Property, Tune Therapeutics
  • Dhara Patel Assistant General Counsel, Intellectual Property, BlueRock Therapeutics
  • David Diamond Vice President & Head Of Intellectual Property, Capstan Therapeutics
  • Marshall Byrd Senior Director IP Management, CureVac

Synopsis

  • Explore timing tactics to extend exclusivity and avoid lifecycle gaps across development and commercialization
  • Examine how lengthy development timelines, especially for advanced therapies, impact optimal patent filing and Loss of Exclusivity (LOE) strategy
  • Learn when to file to support pricing, market entry, and extension eligibility from seasoned IP leaders

2:35 pm Audience Discussion: Planning for the Patent Lifecycle to Anticipate Exclusivity Gaps & Assess the Relevance of the Patent Cliff

Synopsis

  • Share how teams map exclusivity across clinical, regulatory, and IP timelines.
  • Highlight proactive approaches to preventing or mitigating the patent cliff where relevant.
  • Discuss when the patent cliff may be less of a concern for advanced therapies and identify other risks and blind spots in exclusivity planning.

3:05 pm Afternoon Break & Networking

Structuring Platform vs Product IP to Maximize Pipeline Value and Partnering Potential

4:00 pm Deep Dive: Navigating Platform vs Product IP to Maximize Protection, Scalability & Deal Readiness

  • Elbert Chiang Vice President, Intellectual Propery, Beam Therapeutics

Synopsis

This deep dive session will combine a targeted presentation with an interactive roundtable discussion to explore how advanced therapy companies can effectively structure IP across both enabling platforms and therapeutic products.

  • Discover how to build layered IP strategies that differentiate platform claims from product-level protection
  • Analyze real-world approaches to structuring claims and portfolios to enhance licensing leverage and long-term exclusivity
  • Discuss challenges with peers around aligning IP strategy with partnering goals, scalability, and investor expectations

5:00 pm Chair’s Closing Remarks

5:10 pm End of Conference Day One